Related Experiment Video
Updated: Jun 17, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
[Flow cytometric analysis of human malignancies.].
Laeknabladid
|January 13, 2010
Summary
Flow cytometry advances in human tumor analysis, including DNA ploidy and S-phase fraction (SPF) estimation, offer valuable clinical insights. This review details techniques and applications for various cancers and hydatidiform moles.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Oncology
Context:
- Flow cytometry is a powerful technique for analyzing cellular properties.
- Accurate DNA ploidy and S-phase fraction (SPF) analysis are crucial in cancer diagnostics.
- Recent technological advancements have enhanced the capabilities of flow cytometry.
Purpose:
- To review recent advances in flow cytometric analysis of human tumors.
- To discuss the clinical utility of DNA ploidy and SPF estimation in oncology.
- To highlight applications in specific malignancies and gestational trophoblastic diseases.
Summary:
- This article reviews flow cytometry applications in human tumor analysis, focusing on DNA ploidy and S-phase fraction (SPF) estimation.
- It details the technique's principles and clinical usefulness across various cancers, including breast, prostate, and colorectal malignancies.
- The review also covers applications in diagnosing hydatidiform moles.
Impact:
- Provides an updated overview of flow cytometry in tumor diagnostics.
- Facilitates better understanding of flow cytometry's role in cancer prognosis and treatment.
- Supports clinical decision-making by highlighting the utility of specific flow cytometric parameters.
